Alzheimer's Disease Clinical Trials

Showing 1621-1640 of 1,974 trials

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

NCT01825330

The study tests the effect of the NeuroAD on Alzheimer patients' cognitive function. The NeuroAD uses non-invasive stimulation of both magnetic and cognitive training.

Alzheimer's Disease

Neuronix Ltd131 participantsStarted Oct 2013

Sun City, Arizona, United States • Costa Mesa, California, United States • Miami, Florida, United States +7 more locations

UNKNOWNNA

Train the Brain - Cognitive and Physical Training for Slowing Dementia

NCT01725178

Train The Brain is aimed at assessing the efficacy of cognitive and physical training in slowing progression to dementia in patients diagnosed with mild cognitive impairment (MCI).

Mild Cognitive ImpairmentDementiaMemory Disorders

Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy160 participantsStarted Mar 2012

Pisa, Italy

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Train the Brain - Cognitive and Physical Training for Slowing Dementia

Related Searches

Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)

Alzheimer's Disease Multiple Intervention Trial

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion

Bexarotene Amyloid Treatment for Alzheimer's Disease

FluoroAv45 Imaging Research-in Alzheimer's Disease

Computerized Cognitive Training Program for Older Persons With Mild Dementia

A Composite MR Neuroimaging Marker for Alzheimer's Disease

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)

Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads

The Family Caregiver Training Program for Caregivers of People With Dementia

Characteristics of Treatment Responders to Galantamine

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

Coordinating Center for Caregiver Intervention Trial

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

A Longitudinal Multidimensional Population Study on Brain Aging